258 related articles for article (PubMed ID: 18757242)
1. Altered expression of the costimulatory molecules CD80, CD86, CD152, PD-1 and ICOS on T-cells from paracoccidioidomycosis patients: lack of correlation with T-cell hyporesponsiveness.
Cacere CR; Mendes-Giannini MJ; Fontes CJ; Kono A; Duarte AJ; Benard G
Clin Immunol; 2008 Nov; 129(2):341-9. PubMed ID: 18757242
[TBL] [Abstract][Full Text] [Related]
2. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
[TBL] [Abstract][Full Text] [Related]
3. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.
Jun HX; Jun CY; Yu ZX
Haematologica; 2004 Dec; 89(12):1517-24. PubMed ID: 15590404
[TBL] [Abstract][Full Text] [Related]
4. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
[TBL] [Abstract][Full Text] [Related]
5. Expression of costimulatory molecules CD80 and/or CD86 by a Kaposi's sarcoma tumor cell line induces differential T-cell activation and proliferation.
Foreman KE; Wrone-Smith T; Krueger AE; Nickoloff BJ
Clin Immunol; 1999 Jun; 91(3):345-53. PubMed ID: 10370381
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium.
Wang P; Liu Z; Wu C; Zhu B; Wang Y; Xu H
Transplant Proc; 2008 Oct; 40(8):2729-33. PubMed ID: 18929847
[TBL] [Abstract][Full Text] [Related]
7. Reduced alloreactive T-cell activation after alcohol intake is due to impaired monocyte accessory cell function and correlates with elevated IL-10, IL-13, and decreased IFNgamma levels.
Szabo G; Mandrekar P; Dolganiuc A; Catalano D; Kodys K
Alcohol Clin Exp Res; 2001 Dec; 25(12):1766-72. PubMed ID: 11781510
[TBL] [Abstract][Full Text] [Related]
8. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
Wong CK; Lit LC; Tam LS; Li EK; Lam CW
Rheumatology (Oxford); 2005 Aug; 44(8):989-94. PubMed ID: 15870153
[TBL] [Abstract][Full Text] [Related]
9. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
Habib-Agahi M; Phan TT; Searle PF
Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
[TBL] [Abstract][Full Text] [Related]
10. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal Echinococcus multilocularis infection in C57BL/6 mice affects CD40 and B7 costimulator expression on peritoneal macrophages and impairs peritoneal T cell activation.
Mejri N; Gottstein B
Parasite Immunol; 2006 Aug; 28(8):373-85. PubMed ID: 16879309
[TBL] [Abstract][Full Text] [Related]
12. Time courses of B7 family molecules expressed on activated T-cells and their biological significance.
Sun ZW; Qiu YH; Shi YJ; Tao R; Chen J; Ge Y; Hu YM; Ma HB; Shi Q; Zhang XG
Cell Immunol; 2005; 236(1-2):146-53. PubMed ID: 16165113
[TBL] [Abstract][Full Text] [Related]
13. Modulation of cell cycle progression by CTLA4-CD80/CD86 interactions on CD4+ T cells depends on strength of the CD3 signal: critical role for IL-2.
Mukherjee S; Ahmed A; Malu S; Nandi D
J Leukoc Biol; 2006 Jul; 80(1):66-74. PubMed ID: 16624934
[TBL] [Abstract][Full Text] [Related]
14. Modulation of CD28 and CD86 expression in patients with paracoccidioidomycosis in different periods of treatment.
Bozzi A; Reis BS; Prado FL; Pedroso EP; Leite MF; Goes AM
Scand J Immunol; 2004 Nov; 60(5):500-5. PubMed ID: 15541043
[TBL] [Abstract][Full Text] [Related]
15. Cross-species costimulation: relative contributions of CD80, CD86, and CD40.
Rogers NJ; Jackson IM; Jordan WJ; Hawadle MA; Dorling A; Lechler RI
Transplantation; 2003 Jun; 75(12):2068-76. PubMed ID: 12829914
[TBL] [Abstract][Full Text] [Related]
16. Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease.
Trabattoni D; Saresella M; Pacei M; Marventano I; Mendozzi L; Rovaris M; Caputo D; Borelli M; Clerici M
J Immunol; 2009 Oct; 183(8):4984-93. PubMed ID: 19794071
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells from X-linked hyper-IgM patients present impaired responses to Candida albicans and Paracoccidioides brasiliensis.
Cabral-Marques O; Arslanian C; Ramos RN; Morato M; Schimke L; Soeiro Pereira PV; Jancar S; Ferreira JF; Weber CW; Kuntze G; Rosario-Filho NA; Costa Carvalho BT; Bergami-Santos PC; Hackett MJ; Ochs HD; Torgerson TR; Barbuto JA; Condino-Neto A
J Allergy Clin Immunol; 2012 Mar; 129(3):778-86. PubMed ID: 22154528
[TBL] [Abstract][Full Text] [Related]
18. B7-1 and B7-2: similar costimulatory ligands with different biochemical, oligomeric and signaling properties.
Bhatia S; Edidin M; Almo SC; Nathenson SG
Immunol Lett; 2006 Apr; 104(1-2):70-5. PubMed ID: 16413062
[TBL] [Abstract][Full Text] [Related]
19. The effect of specific immunotherapy on the expression of costimulatory molecules in late phase reaction of the skin in allergic patients.
Plewako H; Arvidsson M; Oancea I; Hasséus B; Dahlgren U; Rak S
Clin Exp Allergy; 2004 Dec; 34(12):1862-7. PubMed ID: 15663560
[TBL] [Abstract][Full Text] [Related]
20. B-cell activation in patients with irritable bowel syndrome (IBS).
Ohman L; Lindmark AC; Isaksson S; Posserud I; Strid H; Sjövall H; Simrén M
Neurogastroenterol Motil; 2009 Jun; 21(6):644-50, e27. PubMed ID: 19222763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]